Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07390812 · ClinicalTrials.gov registry record · Early Phase 1
Respiratory Transition Without Continuous Positive Airway Pressure
A Early Phase 1 study of Mild Respiratory Distress, sponsored by Hackensack Meridian Health.
- Active
- Registry status
- Early Phase 1
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT07390812 is a Early Phase 1 study of Mild Respiratory Distress that is active but no longer recruiting, run by Hackensack Meridian Health. The registered enrollment target is 22 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07390812, a Early Phase 1 study of Mild Respiratory Distress, is active but no longer recruiting, sponsored by Hackensack Meridian Health.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary aim of this research project is to determine if term neonates (37:0 to 41:6 weeks' gestational age) with mild respiratory distress can safely transition without continuous positive airway pressure (CPAP). The secondary aim is to determine the incidence of pneumothorax (PTX) for all term neonates assessed to have mild respiratory distress in the delivery room (DR).
Conditions Studied
Interventions
- OTHER Transition without Continuous Positive Airway Pressure (CPAP)
- OTHER CPAP
Study Locations (1)
New Jersey
- Hackensack Univeristy Medical Center - Hackensack
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2023-01-11 |
| Est. Completion | 2026-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07390812
The ClinicalTrials.gov registry entry for NCT07390812 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mild Respiratory Distress appearing as the primary indexed condition, and to 2 interventions - of which Transition without Continuous Positive Airway Pressure (CPAP) is the first listed.
NCT07390812 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT07390812 about?
NCT07390812 is a clinical study titled "Respiratory Transition Without Continuous Positive Airway Pressure". The primary aim of this research project is to determine if term neonates (37:0 to 41:6 weeks' gestational age) with mild respiratory distress can safely transition without continuous positive airway pressure (CPAP). The secondary aim is to determine the incidence of pneumothorax (PTX) for all term ...
What is the current status of trial NCT07390812?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 22 participants. The study started on 2023-01-11. Estimated completion is 2026-12.
What conditions does trial NCT07390812 study?
This clinical trial studies the following conditions: Mild Respiratory Distress.
What interventions are being tested in trial NCT07390812?
The interventions under investigation include: Transition without Continuous Positive Airway Pressure (CPAP) (OTHER), CPAP (OTHER).
Who is sponsoring clinical trial NCT07390812?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07390812 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.